surface
oncology
participate
wainwright
global
healthcare
conference
cambridge
globe
newswire
surface
oncology
nasdaq
surf
company
developing
immunotherapies
target
tumor
microenvironment
today
announced
jeff
goater
chief
executive
officer
robert
ross
chief
medical
officer
participate
upcoming
wainwright
global
healthcare
conference
held
september
discussing
surface
oncology
lead
programs
targeting
targeting
well
surface
emerging
pipeline
highlighted
targeting
aka
pvrig
surface
oncology
surface
oncology
company
developing
antibody
therapies
focused
tumor
microenvironment
pipeline
includes
two
lead
programs
targeting
collaboration
novartis
targeting
two
preclinical
programs
focused
primarily
activating
natural
killer
cells
via
targeting
also
known
pvrig
depleting
regulatory
cells
via
targeting
surface
novel
cancer
immunotherapies
designed
achieve
clinically
meaningful
sustained
response
may
used
alone
combination
therapies
information
please
visit
contacts
investors
matt
lane
matt
